(E,13E)-13-[(4S,5R)-4-hydroxy-5-methyl-2-oxooxolan-3-ylidene]tridec-2-enal

Details

Top
Internal ID 5f28889a-80fd-42d0-bc5b-1024e59b98ac
Taxonomy Organoheterocyclic compounds > Lactones > Gamma butyrolactones
IUPAC Name (E,13E)-13-[(4S,5R)-4-hydroxy-5-methyl-2-oxooxolan-3-ylidene]tridec-2-enal
SMILES (Canonical) CC1C(C(=CCCCCCCCCCC=CC=O)C(=O)O1)O
SMILES (Isomeric) C[C@@H]1[C@H](/C(=C\CCCCCCCCC/C=C/C=O)/C(=O)O1)O
InChI InChI=1S/C18H28O4/c1-15-17(20)16(18(21)22-15)13-11-9-7-5-3-2-4-6-8-10-12-14-19/h10,12-15,17,20H,2-9,11H2,1H3/b12-10+,16-13+/t15-,17-/m1/s1
InChI Key AZUPKVUOQZNWFX-MYOGVJFMSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C18H28O4
Molecular Weight 308.40 g/mol
Exact Mass 308.19875937 g/mol
Topological Polar Surface Area (TPSA) 63.60 Ų
XlogP 4.20
Atomic LogP (AlogP) 3.49
H-Bond Acceptor 4
H-Bond Donor 1
Rotatable Bonds 11

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (E,13E)-13-[(4S,5R)-4-hydroxy-5-methyl-2-oxooxolan-3-ylidene]tridec-2-enal

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8992 89.92%
Caco-2 + 0.5535 55.35%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.6714 67.14%
Subcellular localzation Mitochondria 0.8602 86.02%
OATP2B1 inhibitior - 0.8574 85.74%
OATP1B1 inhibitior + 0.8123 81.23%
OATP1B3 inhibitior + 0.9576 95.76%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior - 0.5795 57.95%
P-glycoprotein inhibitior - 0.6828 68.28%
P-glycoprotein substrate - 0.8345 83.45%
CYP3A4 substrate - 0.5066 50.66%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8846 88.46%
CYP3A4 inhibition - 0.9389 93.89%
CYP2C9 inhibition - 0.8038 80.38%
CYP2C19 inhibition - 0.7941 79.41%
CYP2D6 inhibition - 0.9241 92.41%
CYP1A2 inhibition - 0.6784 67.84%
CYP2C8 inhibition - 0.9203 92.03%
CYP inhibitory promiscuity - 0.8799 87.99%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.8971 89.71%
Carcinogenicity (trinary) Non-required 0.5538 55.38%
Eye corrosion - 0.8559 85.59%
Eye irritation - 0.7870 78.70%
Skin irritation - 0.5185 51.85%
Skin corrosion - 0.9034 90.34%
Ames mutagenesis - 0.5900 59.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7784 77.84%
Micronuclear - 0.8000 80.00%
Hepatotoxicity + 0.5250 52.50%
skin sensitisation - 0.8370 83.70%
Respiratory toxicity - 0.6333 63.33%
Reproductive toxicity + 0.5556 55.56%
Mitochondrial toxicity + 0.5125 51.25%
Nephrotoxicity - 0.6415 64.15%
Acute Oral Toxicity (c) III 0.6134 61.34%
Estrogen receptor binding + 0.5601 56.01%
Androgen receptor binding - 0.5712 57.12%
Thyroid receptor binding + 0.5663 56.63%
Glucocorticoid receptor binding + 0.5406 54.06%
Aromatase binding - 0.6158 61.58%
PPAR gamma + 0.5263 52.63%
Honey bee toxicity - 0.9524 95.24%
Biodegradation + 0.6000 60.00%
Crustacea aquatic toxicity + 0.5737 57.37%
Fish aquatic toxicity + 0.9319 93.19%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.18% 95.56%
CHEMBL2581 P07339 Cathepsin D 91.78% 98.95%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 88.54% 91.11%
CHEMBL3060 Q9Y345 Glycine transporter 2 87.35% 99.17%
CHEMBL1806 P11388 DNA topoisomerase II alpha 85.36% 89.00%
CHEMBL3401 O75469 Pregnane X receptor 85.36% 94.73%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 81.00% 96.47%
CHEMBL1293249 Q13887 Kruppel-like factor 5 80.87% 86.33%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Litsea akoensis

Cross-Links

Top
PubChem 162910918
LOTUS LTS0057757
wikiData Q104921931